Expectations For Sanofi’s Dupixent Successor Drop On Latest Eczema Data Citeline News & Insights Source link
Dupixent: Is a Copay Card Available to Help with Cost? Healthline Source link
For the second time in four years, AbbVie’s Rinvoq (upadacitinib) has shown superior efficacy to Regeneron and Sanofi’s powerhouse Dupixent (dupilumab) in a head-to-head study in patients with atopic dermatitis (AD). In the LEVEL UP trial testing patients age 12 and older with moderate-to-severe AD who had an inadequate response to systemic therapy, 20% of […]
Dupixent® (dupilumab) Late-Breaking Data at AAD Show Significant … GlobeNewswire Source link